top of page
Browse by category
Search
Why obesity takes away the pleasure of eating
A study by scientists at the University of California, Berkeley, suggests that pleasure in eating, even eating junk food, is key to...
Medicare and other insurance should cover obesity drugs
A large majority of older Americans feel that health insurance - including Medicare - should cover anti-obesity medications, according to...
Journal Watch 26/3/2025
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Palatin's oral MC4R Agonist PL7737 receives FDA Orphan Drug Designation for obesity due to leptin receptor deficiency
Palatin Technologies has announced the FDA has granted "orphan drug" designation to PL7737, an oral treatment that activates the...
AI-powered smartphone app constructs 3D model to accurately predict body fat
Researchers from the University of Cambridge have developed a smartphone app that uses machine learning to accurately determine body...
United Biotechnology and Novo Nordisk agree license for UBT251, a GLP-1/GIP/glucagon triple receptor agonist
The United Laboratories International Holdings Limited’s (TUL) wholly-owned subsidiary The United Bio-Technology (Hengqin) Co., Ltd....
Browse by tag
bottom of page